Studi clinici aperti all’arruolamento

Studi clinici chiusi all’arruolamento

Titolo: CUPISCO – “A Phase II, Randomized, Active-Controlled, Multi-Center Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Guided by Genomic Profiling Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site Who Have Received Three Cycles of Platinum Doublet Chemotherapy”

Principal Investigator: Prof. Pierosandro Tagliaferri